Commercializing Continuous Processing in Pharma 2018, Hanson Wade – Commercializing Continuous Processing in Pharma, pharma pricing.#Pharma #pricing

Posted On Jun 5 2018 by

pharma pricing Jan 30 Feb 1, 2018 Register by Friday, December 15 to save up to $500! Agenda Speakers Register Full Event Guide Partnership Opportunities We’re excited to announce the return of the 2 nd annual Commercializing Continuous Processing in Pharma to Boston with exciting project updates and innovative developments in this field. Continuous manufacturing is no longer a buzz word, it’s happening and happening fast: Vertex continues their CP journey with the second commercial rig in New Jersey; Janssen has successfully gained approval for CM in their Italian plant. In addition, it’s not a privilege to small molecules CP …


Drug spending in U, pharma pricing.#Pharma #pricing

Posted On Jun 5 2018 by

Drug spending in U.S. tops the world. Translation: No pricing-headache relief soon What will it take for pharma to get the drug-pricing monkey off its back? A research report this month laid out the pricing landscape, tensions and problems pharma companies face. At the top of the list? The unrivaled access U.S. patients enjoy comes at a cost. Annual per capita spending on prescription drugs in the U.S. is $1,112, about one-third higher than neighboring Canada, which ranked second in the world at $772 spent per person every year. Germany ($741), France ($646) and Spain ($547) rounded out the top …


European Commission – PRESS RELEASES – Press release – Antitrust: Commission opens formal investigation into Aspen Pharma – s pricing practices for cancer medicines, pharma pricing.#Pharma #pricing

Posted On Jun 5 2018 by

Antitrust: Commission opens formal investigation into Aspen Pharma’s pricing practices for cancer medicines Brussels, 15 May 2017 The European Commission has opened a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines. The Commission will investigate whether Aspen has abused a dominant market position in breach of EU antitrust rules. Commissioner Margrethe Vestager, in charge of competition policy, said: “When we get sick, we may depend on specific drugs to save or prolong our lives. Companies should be rewarded for producing these pharmaceuticals to ensure that they keep making them into the …


EpiPen Prices: Mylan CEO Heather Bresch – amp; Big Pharma Scandal, Money, government pricing pharma.#Government #pricing #pharma

Posted On May 16 2018 by

Why the EpiPen Price Scandal Sums Up Everything We Hate About Big Business Politics On Wednesday afternoon, the House Committee on Oversight and Government Reform is hosting a hearing on EpiPen price increases. The meeting follows weeks of reports about outrageous price increases for the life-saving medication, an auto-injection system that provides a dose of epinephrine to ward off anaphylactic shock that can occur during an allergic reaction. Top executives at Mylan, the pharmaceutical company that owns EpiPen, reportedly reaped in nearly $300 million in compensation from 2011 to 2015. The fat payoffs rolled in during a period when the …


Trump s Plan for Drug Pricing Executive Order Is a Big Pharma Wish List, government pricing pharma.#Government #pricing #pharma

Posted On May 16 2018 by

government pricing pharma Kelly Hayes of Truthout: Treating “predators” who commit sexual violence as outliers won’t change the norms and practices that make sexual violence inevitable in this society. Nor does it offer material and emotional support to victims. To Stop Keystone XL, 8,000 People in Just 24 Hours Make “Promise to Protect” TransCanada has many hurdles still ahead on Keystone XL, and if they ever run out, thousands of people have promised to be the biggest one. Trump s Plan for Drug Pricing Executive Order Is a Big Pharma Wish List (Photo: TBIT; Edited: LW / TO) Raise your …


Trump to pharma: You – re – getting away with murder, and I – m the one to stop it, FiercePharma, government pricing pharma.#Government #pricing #pharma

Posted On May 16 2018 by

Trump to pharma: You re getting away with murder, and I m the one to stop it Remember the Trump euphoria that hit biopharma stocks after the president-elect captured the Electoral College in November? Well, scratch that. At his first press conference since July, Trump said Wednesday that the industry is “getting away with murder”—and the government needs to take action. Trump said the government should require competitive bidding to get drug costs down, claiming that the U.S. can save “billions of dollars” with such a process. He called out pharma lobbyists and their power in Washington. And, repeating a …


Market Access, Pricing, Value and Evidence, Pharma Pricing 2018, 20 – 21 March 2018, government pricing pharma.#Government #pricing #pharma

Posted On May 16 2018 by

Market Access, Pricing, Value and Evidence Carla Deakin, Associate Director, Office for Market Access, NICE Carla DeakinAssociate Director, Office for Market Access (OMA), National Institute for Health and Care Excellence.В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В Originally a biomedical scientist in the NHS, Carla spent 25 years in the UK Diagnostics industry, gaining both commercial and healthcare. Sebastien Le Roux, VP, Global Market …


Trump to pharma: You – re – getting away with murder, and I – m the one to stop it, FiercePharma, government pricing pharma.#Government #pricing #pharma

Posted On May 16 2018 by

Trump to pharma: You re getting away with murder, and I m the one to stop it Remember the Trump euphoria that hit biopharma stocks after the president-elect captured the Electoral College in November? Well, scratch that. At his first press conference since July, Trump said Wednesday that the industry is “getting away with murder”—and the government needs to take action. Trump said the government should require competitive bidding to get drug costs down, claiming that the U.S. can save “billions of dollars” with such a process. He called out pharma lobbyists and their power in Washington. And, repeating a …


Home Page, PhRMA, pharmaceutical pricing.#Pharmaceutical #pricing

Posted On Mar 20 2018 by

pharmaceutical pricing PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource Library, …


Commercializing Continuous Processing in Pharma 2018, Hanson Wade – Commercializing Continuous Processing in Pharma, pharma pricing.#Pharma #pricing

Posted On Mar 6 2018 by

pharma pricing Jan 30 Feb 1, 2018 Register by Friday, December 15 to save up to $500! Agenda Speakers Register Full Event Guide Partnership Opportunities We’re excited to announce the return of the 2 nd annual Commercializing Continuous Processing in Pharma to Boston with exciting project updates and innovative developments in this field. Continuous manufacturing is no longer a buzz word, it’s happening and happening fast: Vertex continues their CP journey with the second commercial rig in New Jersey; Janssen has successfully gained approval for CM in their Italian plant. In addition, it’s not a privilege to small molecules CP …